0001209191-20-043803.txt : 20200728
0001209191-20-043803.hdr.sgml : 20200728
20200728090107
ACCESSION NUMBER: 0001209191-20-043803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200724
FILED AS OF DATE: 20200728
DATE AS OF CHANGE: 20200728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Joseph Donald
CENTRAL INDEX KEY: 0001319460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 201052036
MAIL ADDRESS:
STREET 1: C/O KALOBIOS PHARMACEUTICALS, INC.
STREET 2: 260 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-24
0
0001069308
Acer Therapeutics Inc.
ACER
0001319460
Joseph Donald
C/O ACER THERAPEUTICS INC.
300 WASHINGTON STREET., STE 351
NEWTON
MA
02458
0
1
0
0
Chief Legal Officer and Secy
Common Stock
2020-07-24
4
P
0
14285
3.50
A
14285
D
/s/ Donald Joseph
2020-07-28